NSRX Competitors & Alternatives
Compare Nasus Pharma Ltd. with similar stocks in the same industry
Drug Manufacturers - General
NSRX
Main Stock$3.49
Tradestie Score
54
Market Cap
$54.36M
Analyst Upside
+463.5%
Top Competitors
22 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BMY
Bristol-Myers Squibb Co.
|
$61.48
|
$96.54B | 13.9 | 61 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$50.75
|
$91.59B | 16.2 | 35 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$250.69
|
$22.61B | 45.1 | 43 | Compare |
|
GRFS
Grifois, S.A.
|
$7.56
|
$6.78B | 9.8 | 55 | Compare |
|
OGN
Organon & Co.
|
$13.75
|
$2.86B | 17.6 | 51 | Compare |
|
MDCX
Medicus Pharma Ltd. Common Stock
|
$2.50
|
$45.85M | - | 30 | Compare |
|
APUS
Apimeds Pharmaceuticals US, Inc.
|
$2.89
|
$21.50M | - | 51 | Compare |
|
NCEL
NCEL
|
$2.66
|
$14.79M | 4.9 | 49 | Compare |
|
OPTH
OPTH
|
$3.25
|
- | - | 51 | Compare |
|
PLYX
PLYX
|
$1.85
|
- | - | 42 | Compare |
More NSRX Analysis
Data updated: Oct 25, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
22 stocks in this industry